CS1, a controlled‐release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical trial

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Raymond L. Benza, Philip B. Adamson, Deepak L. Bhatt, Fredrik Frick, Gunnar Olsson, Niklas Bergh, Björn Dahlöf
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Pulmonary Circulation
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet